Precision Health Research, Singapore (PRECISE) has established a partnership with Alnylam, Bayer, Boehringer Ingelheim, and Novo Nordisk to advance precision medicine research specifically tailored to Asian populations.

• Genomic Dataset: The collaboration utilises the PRECISE-SG100K dataset, one of the largest non-European population datasets, to study health risk factors in Asians.
• Infrastructure: Industry and academic researchers will be granted controlled access to anonymised data in compliance with Singapore’s data privacy regulations.
• Strategic Focus: The initiative addresses diversity gaps in global genomic research to support the development of novel diagnostics and treatments for the region.

This summary is based on a press release issued by PRECISE.